Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by pierre013on May 10, 2017 7:54pm
322 Views
Post# 26228931

RE:RE:RE:CMO Manufacturing PPPS

RE:RE:RE:CMO Manufacturing PPPSI was at the AGM and I asked the question in french about how they will achieve the $8 Billion target for the U.S. market.The presentation from Bruce was too short and was not detailed enough IMO. Pierre explained that Belleville will come with 400,000 L. Like they already have the building,I don't think it will take too long to deserve the market.For Taiwan, Hematech wants to get at least 5 or 6 approved proteins before starting any commercial production. From what I understand with the comments from Pierre on DFU, I think that the CMO's will wait to see the clinical results from the DFU approved before diving in the pool. For the rest, I'm confortable from what I heard and felt from the managemet.PLI is at a crucial crossing right now and they will pass trough it with the commitment of their staff, employees and their shareholders. Everything else is noise...
Bullboard Posts